Biotinylated Rh(III) complexes in engineered streptavidin for accelerated asymmetric C-H activation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23112327.
- Also identified by DOI 10.1126/science.1226132 and PMC identifier 3820005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Enzymes provide an exquisitely tailored chiral environment to foster high catalytic activities and selectivities, but their native structures are optimized for very specific biochemical transformations. Designing a protein to accommodate a non-native transition metal complex can broaden the scope of enzymatic transformations while raising the activity and selectivity of small-molecule catalysis. Here, we report the creation of a bifunctional artificial metalloenzyme in which a glutamic acid or aspartic acid residue engineered into streptavidin acts in concert with a docked biotinylated rhodium(III) complex to enable catalytic asymmetric carbon-hydrogen (C-H) activation. The coupling of benzamides and alkenes to access dihydroisoquinolones proceeds with up to nearly a 100-fold rate acceleration compared with the activity of the isolated rhodium complex and enantiomeric ratios as high as 93:7.
Medical subject headings
- Alkenes
- Alkenes/chemistry
- Benzamides
- Benzamides/chemistry
- Biotinylation
- Carbon
- Carbon/chemistry
- Catalysis
- Catalytic Domain
- Coordination Complexes
- Coordination Complexes/chemistry
- Enzyme Activation
- Enzymes
- Enzymes/chemistry
- Hydrogen
- Hydrogen/chemistry
- Mutagenesis, Site-Directed
- Protein Engineering
- Rhodium
- Rhodium/chemistry
- Streptavidin
- Streptavidin/chemistry
- Streptavidin/genetics
- Substrate Specificity